Osteoporosis drug also promotes infiltration of immune cells in breast tumors
The team of Eva González-Suarez, from the CNIO and IDIBELL, and the team of Christos Sotiriou, from the Jules Bordet Institute, demonstrate that a drug already used to treat osteoporosis promotes the infiltration of immune cells in breast tumors
These findings propose a new target to increase the antitumor immune response and make breast cancer more sensitive to immunotherapy
Despite the success of immunotherapy in the treatment of cancers such as lung or melanoma, it is still not effective in breast cancers for being 'cold', with low infiltration of immune cells.